Monocarboxylate Transporter 1 Deficiency and Ketone Utilization
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summ a r yKetoacidosis is a potentially lethal condition caused by the imbalance between hepatic production and extrahepatic utilization of ketone bodies.We performed exome sequencing in a patient with recurrent, severe ketoacidosis and identified a homozygous frameshift mutation in the gene encoding monocarboxylate transporter 1 (SLC16A1, also called MCT1).Genetic analysis in 96 patients suspected of having ketolytic defects yielded seven additional inactivating mutations in MCT1, both homozygous and heterozygous.Mutational status was found to be correlated with ketoacidosis severity, MCT1 protein levels, and transport capacity.Thus, MCT1 deficiency is a novel cause of profound ketoacidosis; the present work suggests that MCT1mediated ketone-body transport is needed to maintain acid-base balance.A cetoacetate and 3-hydroxybutyrate are slightly acidic biomolecules that, together with acetone, are called ketone bodies and serve as the major circulating energy source during fasting.Ketone bodies are formed in the liver from the ultimate breakdown product of fatty acids -acetyl coenzyme A (CoA) -by coupling of two acetyl units in a three-step enzymatic process called ketogenesis.Ketone bodies are believed to undergo passive distribution to metabolically active tissues, where they are used as an energy source. 1 Ketoacidosis, a pathologic state, occurs when ketone formation exceeds ketone utilization.The clinical consequences of ketoacidosis are exemplified by diabetic ketoacidosis, a condition that is marked by vomiting, osmotic diuresis, dehydration, and Kussmaul breathing and that may progress to decreased consciousness and, ultimately, death. 2 Inborn errors of ketone utilization are manifested similarly; however, glucose levels in these types of ketoacidosis are normal or even low, in contrast to glucose levels in diabetic ketoacidosis.3 Only two genetic causes of recurrent ketoacidosis are currently known: succinyl CoA oxoacid transferase (SCOT) deficiency (Online Mendelian Inheritance in Man [OMIM] database number, 245050) and mitochondrial acetoacetyl-CoA thiolase (ACAT1) deficiency (also called beta-ketothiolase deficiency; OMIM number, 203750).Both SCOT and ACAT1 are involved in ketolysis, the breakdown of ketone bodies into the key cellular energy source, acetyl CoA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664
Metabolic profiles in children during fasting
van Veen, M. R., van Hasselt, P. M., de Sain-van der Velden, M. G. M., Verhoeven, N., Hofstede, F. C., de Koning, T. J., & Visser, G. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1706 · Cited by 86
Cited by
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,610
Monocarboxylate transporters in cancer
Payen, V. L., Mina, E., Van Hée, V. F., Porporato, P. E., & Sonveaux, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.006 · Cited by 644
Thornton, P. S., Stanley, C. A., De Leon, D. D., Harris, D., Haymond, M. W., Hussain, K., Levitsky, L. L., Murad, M. H., Rozance, P. J., Simmons, R. A., et al. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.03.057 · Cited by 625
“37,38 Nonspecific treatment with glucocorticoids for neonates with hypoglycemia is discouraged.”
Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates
Wang, N., Jiang, X., Zhang, S., Zhu, A., Yuan, Y., Xu, H., Lei, J., & Yan, C. (2021) · Cell · doi:10.1016/j.cell.2020.11.043 · Cited by 340
Metabolic and Signaling Roles of Ketone Bodies in Health and Disease
Puchalska, P., & Crawford, P. A. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-111120-111518 · Cited by 282
Metadata
- Authors
- van Hasselt, P. M., Ferdinandusse, S., Monroe, G. R., Ruiter, J. P. N., Turkenburg, M., Geerlings, M. J., Duran, K., Harakalova, M., van der Zwaag, B., Monavari, A. A., Okur, I., Sharrard, M. J., Cleary, M., O’Connell, N., Walker, V., Rubio-Gozalbo, M. E., de Vries, M. C., Visser, G., Houwen, R. H. J., van der Smagt, J. J., Verhoeven-Duif, N. M., Wanders, R. J. A., & van Haaften, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-11-13
- Volume
- 371
- Issue
- 20
- Pages
- 1900-1907
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2098176814
- Cited by
- 120
- References
- 2
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monocarboxylate Transporter 1 Deficiency and Ketone Utilization. https://app.cochat.ai/papers/10.1056/nejmoa1407778
- The paper
- van Hasselt, P. M., Ferdinandusse, S., Monroe, G. R., Ruiter, J. P. N., Turkenburg, M., Geerlings, M. J., Duran, K., Harakalova, M., van der Zwaag, B., Monavari, A. A., Okur, I., Sharrard, M. J., Cleary, M., O’Connell, N., Walker, V., Rubio-Gozalbo, M. E., de Vries, M. C., Visser, G., Houwen, R. H. J., . . . van Haaften, G. (2014). Monocarboxylate Transporter 1 Deficiency and Ketone Utilization. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1407778
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.